Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
13 janv. 2022 08h19 HE
|
Biomerica, Inc.
Revenues up 239% over prior year fiscal second quarter Customer orders backlog of over $4.0 million at November 30, 2021 Walmart began in-store and online sales of Biomerica’s EZ Detect™ Colon...
AnPac Bio Class III Medical Device Passes Extensive NMPA Registration Tests and Will Start Clinical Trial in Q1, 2022
04 janv. 2022 07h30 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Jan. 04, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a US and China-based biotechnology company focused on early cancer...
Insights on the Lung Cancer Diagnostics Global Market to 2027 - Featuring Illumina, Abbott Laboratories and Thermo Fisher Scientific Among Others
30 déc. 2021 04h23 HE
|
Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Lung Cancer Diagnostics Market Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis" report has...
The Colorectal Cancer Screening Market is Expected to Register a CAGR of 5.4% in the Forecast Period of 2021-2026
23 déc. 2021 06h33 HE
|
Research and Markets
Dublin, Dec. 23, 2021 (GLOBE NEWSWIRE) -- The "Colorectal Cancer Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's...
United States and Canada Cervical Cancer Screening Industry Forecast to Reach US$ 8.2 Billion by 2027
13 déc. 2021 04h18 HE
|
Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "United States and Canada Cervical Cancer Screening Market, Forecast 2022-2027, Industry Trends, Impact of COVID-19, Company Analysis" report has been...
Technical Paper on AnPac Bio Novel CDA Cancer Detection Technology Published by Peer-Reviewed International Medical Journal
10 déc. 2021 07h30 HE
|
AnPac Bio-Medical Science Co., Ltd.
PHILADELPHIA, Dec. 10, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
CORRECTION -- Anpac Bio, USA
11 nov. 2021 03h19 HE
|
Anpac Bio, USA
PHILADELPHIA, Nov. 11, 2021 (GLOBE NEWSWIRE) -- In its press release dated November 9, 2021 entitled “AnPac Bio Announces Pricing of Approximately $2.9 Million Underwritten Public Offering of...
AnPac Bio Announces Pricing of Approximately $2.9 Million Underwritten Public Offering of American Depositary Shares
09 nov. 2021 23h55 HE
|
Anpac Bio, USA
PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC, the “Company”), a biotechnology company with operations in China and the United States focusing on...
UPDATE - AnPac Bio Commences Proposed Public Offering of American Depositary Shares
09 nov. 2021 17h21 HE
|
Anpac Bio, USA
PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC, the “Company”), a biotechnology company with operations in China and the United States focusing on...
AnPac Bio Commences Proposed Public Offering of American Depositary Shares
09 nov. 2021 16h59 HE
|
Anpac Bio, USA
SUNRISE, Fla., Nov. 09, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC, the “Company”), a biotechnology company with operations in China and the United States focusing on...